Metabolomic in Critical Ill Patients

Metabolomic Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01506674
• Other study ID #: HSR CEmet
• Status: Terminated
• Start date: January 27, 2015
• Est. completion date: April 6, 2023

Study information

• Verified date: January 2024
• Source: Università Vita-Salute San Raffaele
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 94
• Est. completion date: April 6, 2023
• Est. primary completion date: October 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• patients with severe left or right ventricular dysfunction undergoing cardiac surgery

• patients undergoing ablation of ventricular tachycardia

• patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases

• patients undergoing thoracoabdominal vascular surgery

Exclusion Criteria:

• pregnant women

• no written consent

Related Conditions & MeSH terms

• Metabolomic

Locations

Country	Name	City	State
Italy	Università Vita-Salute San Raffaele	Milano	Mi

Sponsors (1)

Lead Sponsor	Collaborator
Università Vita-Salute San Raffaele

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Metabolomic patterns to identify poor outcome		hospital stay (approximately two weeks)